Dr. Frankfurt's clinical research is aimed at developing novel therapeutic modalities for treatment of hematological malignancies. As a lead investigator on various clinical trials she works to identify and design optimal curative strategies based on the individual patient and disease characteristics. At Northwestern, she has developed one of the largest umbilical cord blood programs in the nation. This successful program provides lifesaving therapies for patients without adult donor options. She is actively involved in developing a haploidentical program at Northwestern as well as other immunological interventions such as Car-T cell, NK cells therapies.

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals

Follow Us

facebook instagram twitter youtube


Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect


Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811